Dulaglutide recalls
The FDA has published 2 recalls involving Dulaglutide since 2021. The latest was reported on 25 May 2022. Cardinal Health has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2021
Last 12 months0reported
Class I00% of total
Ongoing0latest 25 May 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why dulaglutide is recalled
Companies
By year
All dulaglutide recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Trulicity (dulaglutide) injection, 0.75 mg/ once weekly-Dose Pens recalledTrulicity | Cardinal Health | Temperature Abuse | NM |
| Drug | CLASS II | Trulicity (dulaglutide), 0.75 mg/-Dose Pens recalled by Eli Lilly &Trulicity | Eli Lilly | Other | Nationwide |
Should you stop taking Dulaglutide?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.